a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
Industry MedicalSpecialties
A.I.dvisor tells us that TELA and SRTS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and SRTS's prices will move in lockstep.
Ticker / NAME | Correlation To TELA | 1D Price Change % | ||
---|---|---|---|---|
TELA | 100% | -0.65% | ||
SRTS - TELA | 29% Poorly correlated | +5.96% | ||
NEOG - TELA | 26% Poorly correlated | -3.56% | ||
BAX - TELA | 26% Poorly correlated | -2.85% | ||
OMIC - TELA | 26% Poorly correlated | +0.98% | ||
GH - TELA | 26% Poorly correlated | -4.43% | ||
More |
Ticker / NAME | Correlation To TELA | 1D Price Change % |
---|---|---|
TELA | 100% | -0.65% |
Medical Specialties industry (417 stocks) | 9% Poorly correlated | -1.54% |
Medical Specialties industry (427 stocks) | 9% Poorly correlated | -1.35% |